X-ray diffraction (XRD): the phase analysis was conducted by X-ray powder diffraction (XRD) employing an XRPD, Bruker D8 using CuKα radiation, λ= 1.54060 A°, graphite monochromator, 40 kV-30 mA, 2θ= ...

WAXS diffractograms were recorded on a Bruker D8 Discover X-ray diffractometer equipped with a Bruker IμS Diamond Cu K α source and scintillation counter using a Bruker Våntec-500 2D detector.

2.2. Residual Stress Measurements The X-ray diffraction measurements were carried out using Cr Ka X-rays from a tube operated at 35 kV and 40 mA through a 0.5 mm diameter total reflection collimetor ...

FTIR spectroscopy was performed on a TENSOR27 FTIR spectrometer (Bruker, Karlsruhe, Germany). XPS analyses were carried out on an X-ray photoelectron spectrometer (Kratos, Manchester, UK). XRD was ...

Bruker exceeded both EPS and revenue forecasts for Q4 2024. The company reported a 14.6% year-over-year increase in quarterly revenue. Stock price decreased by 0.77% despite the earnings beat ...

2025 Non-GAAP EPS Guidance: $2.67 to $2.72, representing 11% to 13% growth. Bruker Corp (NASDAQ:BRKR) reported a strong Q4 2024 with a 14.6% year-over-year increase in revenues, reaching $979.6 ...

Bruker (BRKR) reported $979.6 million in revenue for the quarter ended December 2024, representing a year-over-year increase of 14.6%. EPS of $0.76 for the same period compares to $0.70 a year ago.

(3) Bruker Scientific Instruments (BSI) revenue reflects the sum of the BSI BioSpin, CALID and Nano Segments as presented in our Annual Report on Form 10-K for the year ended December 31 ...

In its fourth quarter 2024 investor letter, The London Company SMID Cap Strategy emphasized stocks such as Bruker Corporation (NASDAQ:BRKR). Bruker Corporation (NASDAQ:BRKR) focuses on developing ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...